The Register · A provider

Parc Sanitari Sant Joan de Déu

Barcelona · Spain

Specialties

psychiatric research treatment-resistant depression psilocybin clinical trials psychedelic research ketamine trials psilocybin trials MDMA trials 5-MeO-DMT trials

Reports that name this provider

Psilocybin Treatment Legality in Spain: COMPASS Pathways COMP006 Phase 3 trial site
Psychedelic Treatment Quality in Spain: Houses the ANIMA psychedelic research group. Dr. Óscar Soto Angona (psychiatrist, Vice President of SEMPsi) conducts research across ketamine, psilocybin, MDMA, and 5-MeO-DMT trials. Participates in Beckley Psytech's Phase 2b BPL-003 trial (5-MeO-DMT for treatment-resistant depression).

← Back to all clinics